PEP0418

Invitrogen™ Human PKR Synthetic Peptide

Manufacturer: Invitrogen™

Select a Size

Pack Size SKU Availability Price
Each of 1 PEP0418-Each-of-1 In Stock ₹ 16,247.84

PEP0418 - Each of 1

₹ 16,247.84

In Stock

Quantity

1

Base Price: ₹ 16,247.84

GST (18%): ₹ 2,924.611

Total Price: ₹ 19,172.451

Gene ID (Entrez)

5610

Purification Method

purified

Common Name

Human PKR

Content And Storage

-20°C

Format

Liquid

For Use With (Application)

Blocking Assay, Control

Lyophilized

No

Product Type

Peptide

Regulatory Status

RUO - research use only

Species

Human

Accession Number

P19525

Concentration

200 μg/mL

Description

Synthetic Peptide

Formulation

PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2

Gene Symbol

EIF2AK2

Preservative

0.02% sodium azide

Quantity

50 μg

Storage Buffer

PBS

Related Products

Img

Invitrogen™

PEP0187

--

Img

Invitrogen™

PEP0072

--

Img

Invitrogen™

PEP0078

--

Img

Invitrogen™

PEP0085

--

Img

Invitrogen™

PEP0351

--

Img

Invitrogen™

PEP0389

--

Img

Invitrogen™

PEP0390

--

Img

Invitrogen™

PEP0404

--

Description

  • PKR Synthetic Peptide, PEP-0418, from Invitrogen
  • PKR is a 68 kDa protein and an IFN-induced serine/threonine protein kinase consisting of two N-terminal RNA-binding regulatory domains and a functional C-terminal serine/threonine protein kinase domain
  • Activated by dsRNA produced during viral infections, PKR plays a key role in IFN induced-innate antiviral response, virus-induced apoptosis, cell growth and differentiation
  • Upon activation, PKR gets autophosphorylated and catalyzes the phosphorylation of elF2 alpha subunit, which leads to an inhibition of protein synthesis
  • PKR induces apoptosis by up-regulating Fas expression and mediates FADD/Caspase-8 death signaling pathway
  • Upon viral infection, it functions as a dual protein, sequentially activating both cell survival and cell death pathways using kinase independent and dependent strategies
  • PRKR regulates multiple pathways which include NF-kappaB activation, p53, p38, and PDGF signaling pathway
  • PKR has been implicated in tumor suppression and malignancy
  • To evade the antiviral effects of PKR, viruses have evolved multiple mechanisms, such as the inhibition of PKR by the non-structural protein (NS1) of the influenza virus
  • More recently, PKR has been implicated in several neurodegenerative diseases including Alzheimer, Huntington, and amyotrophic lateral sclerosis
  • This peptide corresponds to 14 amino acids near the amino terminus of human PKR.PEP-0418 can be used as a blocking peptide with polyclonal antibody PA5-20284.

Compare Similar Items

Show Difference

Img

Invitrogen™

PEP0418

--


Gene ID (Entrez):
5610

Purification Method:
purified

Common Name:
Human PKR

Content And Storage:
-20°C

Format:
Liquid

For Use With (Application):
Blocking Assay, Control

Lyophilized:
No

Product Type:
Peptide

Regulatory Status:
RUO - research use only

Species:
Human

Accession Number:
P19525

Concentration:
200 μg/mL

Description:
Synthetic Peptide

Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2

Gene Symbol:
EIF2AK2

Preservative:
0.02% sodium azide

Quantity:
50 μg

Storage Buffer:
PBS

Img

Invitrogen™

PEP0420

--


Gene ID (Entrez):
6591

Purification Method:
purified

Common Name:
Human SLUG

Content And Storage:
-20°C

Format:
Liquid

For Use With (Application):
Blocking Assay, Control

Lyophilized:
No

Product Type:
Peptide

Regulatory Status:
RUO - research use only

Species:
Human

Accession Number:
O43623

Concentration:
200 μg/mL

Description:
Synthetic Peptide

Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2

Gene Symbol:
SNAI2

Preservative:
0.02% sodium azide

Quantity:
50 μg

Storage Buffer:
PBS

Img

Invitrogen™

PEP0421

--


Gene ID (Entrez):
8600

Purification Method:
purified

Common Name:
Human CD254 (RANK Ligand) (soluble)

Content And Storage:
-20°C

Format:
Liquid

For Use With (Application):
Blocking Assay, Control

Lyophilized:
No

Product Type:
Peptide

Regulatory Status:
RUO - research use only

Species:
Human

Accession Number:
O14788

Concentration:
200 μg/mL

Description:
Synthetic Peptide

Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2

Gene Symbol:
TNFSF11

Preservative:
0.02% sodium azide

Quantity:
50 μg

Storage Buffer:
PBS

Img

Invitrogen™

PEP0423

--


Gene ID (Entrez):
867

Purification Method:
purified

Common Name:
Human c-Cbl

Content And Storage:
-20°C

Format:
Liquid

For Use With (Application):
Blocking Assay, Control

Lyophilized:
No

Product Type:
Peptide

Regulatory Status:
RUO - research use only

Species:
Human

Accession Number:
P22681

Concentration:
200 μg/mL

Description:
Synthetic Peptide

Formulation:
PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2

Gene Symbol:
CBL

Preservative:
0.02% sodium azide

Quantity:
50 μg

Storage Buffer:
PBS